- NewLink Genetics Corp (NASDAQ:NLNK) tumbled 32.8 percent to $7.14. NewLink Genetics disclosed that Genentech intends to return the rights of IDO inhibitor GDC-0919 back to the company.
- MoSys Inc. (NASDAQ:MOSY) shares dipped 23.4 percent to $1.42 after jumping 125.61 percent on Wednesday.
- USD Partners LP (NASDAQ:USDP) declined 15.4 percent to $11.00. USD Partners reported an offering of 3 million common units.
- MidSouth Bancorp, Inc. (NYSE:MSL) shares dropped 13.2 percent to $12.25. MidSouth Bancorp reported pricing of upsized offering of 4.58 million shares of common stock at $12 per share.
- Invacare Corporation (NYSE:IVC) shares declined 13.1 percent to $11.77. Invacare reported a proposed offering of $100 million aggregate principal amount of convertible senior notes due 2022.
- Camtek LTD. (NASDAQ:CAMT) shares dropped 12.3 percent to $5.82.
- Mazor Robotics Ltd - ADR (NASDAQ:MZOR) shares slipped 9.8 percent to $33.71 after dropping 3.96 percent on Wednesday.
- Urban Outfitters, Inc. (NASDAQ:URBN) shares slipped 8.2 percent to $16.75 after rising 0.22 percent on Wednesday.
- Greif, Inc. (NYSE:GEF) shares slipped 6.1 percent to $56.14 after the company posted downbeat quarterly earnings.
- Shotspotter Inc (NASDAQ:SSTI) shares declined 4.7 percent to $13.70 after surging 30.73 percent on Wednesday.
- Vail Resorts, Inc. (NYSE:MTN) dropped 3.5 percent to $207.51 after the company posted downbeat quarterly results.
- Hawaiian Holdings, Inc. (NASDAQ:HA) slipped 3.5 percent to $57.25. Deutsche Bank downgraded Hawaiian Holdings from Buy to Hold.
- W. R. Grace & Co (NYSE:GRA) declined 3.4 percent to $69.05. Goldman Sachs downgraded W. R. Grace from Buy to Neutral.
- Polarityte Inc (NASDAQ:COOL) fell 3.3 percent to $18.60 after the company reported pre-clinical results for its lead product, SkinTE™.
- Juno Therapeutics Inc (NASDAQ:JUNO) slipped 2.6 percent to $23.12. BTIG Research downgraded Juno Therapeutics from Neutral to Sell.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
